Grace Therapeutics GRCE

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: Princeton, New Jersey
Fiscal year end: 03/31
Next earnings: 11/13, estimated

No member of Congress reported a trade in Grace Therapeutics GRCE in the past 90 days. Insiders filed 2 purchases and 0 sales on the open market over the same period, a net purchase of $31.7K.

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: +$31.7K; Last 90 days · bought $31.7K · sold $0
Next earnings: 11/13; Estimated from the last four quarters

26-week trading

Common questions

Did Grace Therapeutics GRCE insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 2 purchases and 0 sales on the open market. Purchases came to $31.7K.